Prescription drug · NDA
Lutrate Depot (Leuprolide acetate) NDC 83831-134
Kit · Avyxa Pharma, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 83831-134-01 | 8383101340183831013401 | 1 KIT in 1 CARTON (83831-134-01) * 2 mL in 1 VIAL, SINGLE-DOSE (83831-150-22) * 2 mL in 1 SYRINGE (83831-135-02)Marketed from Mar 26, 2025 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Lutrate Depot
- Generic name (nonproprietary)
- leuprolide acetate
- Dosage form
- Kit
- Labeler
- Avyxa Pharma, LLCNDC labeler code 83831
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 205054
- Marketing start
- Listing expires
- Identifiers
- Product ID 83831-134_d4332d30-8a83-4118-88bb-3c49851837b6SPL ID d4332d30-8a83-4118-88bb-3c49851837b6SPL set ID 3a6d1373-17d9-4289-b62f-d299ffe55831RxCUI 2606516, 2709448
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- NDC on a medical claim
N483831013401followed by a unit qualifier and the quantityPackage 83831-0134-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
LUTRATE DEPOT 22.5 mg for 3-month administration (leuprolide acetate) is indicated for treatment of advanced prostate cancer. LUTRATE DEPOT is a gonadotropin-releasing hormone (GnRH) agonist indicated for: Treatment of advanced prostate cancer. ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 83831-134
- What is NDC 83831-134?
- 83831-134 is the product NDC for Lutrate Depot (leuprolide acetate) kit, listed with the FDA by Avyxa Pharma, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Lutrate Depot (Leuprolide acetate).
- Who is the labeler?
- Avyxa Pharma, LLC, NDC labeler code 83831. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Lutrate Depot?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Other NDCs under NDA 205054
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Leuprolide Acetate Depotleuprolide acetate | — | Kit | CIPLA USA INC. | 69097-909 |